Horiguchi J, Yamashita H, Mizuno S, Kuramoto Y, Kagaya A, Yamawaki S, Inami Y
Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, Hiroshima City, Japan.
Int Clin Psychopharmacol. 1999 Jan;14(1):33-6.
Nocturnal eating/drinking syndrome secondary to neuroleptic-induced restless legs syndrome (RLS) occurred under treatment with low-dose haloperidol in a 51-year-old female schizophrenic patient. Polysomnographic investigation showed a low level of sleep efficacy, periodic leg movements, and a strict relationship between nocturnal eating episodes and non-rapid eye movement sleep. Her nocturnal eating and RLS were completely inhibited by clonazepam treatment. To our knowledge, this is the first published case of nocturnal eating/drinking syndrome secondary to neuroleptic-induced RLS.
一名51岁女性精神分裂症患者在接受低剂量氟哌啶醇治疗时,出现了由抗精神病药物诱发的不安腿综合征(RLS)继发的夜间饮食综合征。多导睡眠图检查显示睡眠效率低下、周期性腿部运动,且夜间进食发作与非快速眼动睡眠之间存在密切关系。氯硝西泮治疗完全抑制了她的夜间进食和RLS。据我们所知,这是首例发表的由抗精神病药物诱发的RLS继发的夜间饮食综合征病例。